NCT06854094View on ClinicalTrials.gov

Consolidation Therapy with Cladribine in Relapsing Multiple Sclerosis Patients

RecruitingOBSERVATIONAL

Enrollment

70

Participants

Timeline

Start Date

October 3, 2024

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2028

Conditions

Multiple Sclerosis

Trial Locations (1)

6903

RECRUITING

Ospedale Regionale di Lugano, Istituto di Neuroscienze Cliniche della Svizzera Italiana, Via Tesserete 46,, Lugano

Sponsors

Collaborators (1)

3B Biotech Research

All Listed Sponsors

collaborator

3B Biotech Research

OTHER

lead

Ente Ospedaliero Cantonale, Bellinzona

OTHER

NCT06854094 - Consolidation Therapy with Cladribine in Relapsing Multiple Sclerosis Patients | Biotech Hunter | Biotech Hunter